Similar articles for PMID: 18693096

Year	Number of Results
1984	1
1985	1
1987	1
1988	1
1990	3
1991	2
1992	5
1993	5
1994	6
1995	3
1996	5
1997	5
1998	7
1999	12
2000	14
2001	6
2002	6
2003	14
2004	21
2005	15
2006	32
2007	45
2008	76
2009	31
2010	8
2011	14
2012	14
2013	15
2014	11
2015	15
2016	7
2017	9
2018	11
2019	4
2020	5
2021	6
2022	1
2024	0

1

The ovariectomized, mature rat model of postmenopausal osteoporosis: an assessment of the bone sparing effects of curcumin.

French DL, Muir JM, Webber CE. French DL, et al. Phytomedicine. 2008 Dec;15(12):1069-78. doi: 10.1016/j.phymed.2008.06.007. Epub 2008 Aug 6. Phytomedicine. 2008. PMID: 18693096

2

Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.

Fox J, Miller MA, Newman MK, Metcalfe AF, Turner CH, Recker RR, Smith SY. Fox J, et al. Calcif Tissue Int. 2006 Oct;79(4):262-72. doi: 10.1007/s00223-006-0108-1. Epub 2006 Sep 11. Calcif Tissue Int. 2006. PMID: 16969596

3

Flaxseed combined with low-dose estrogen therapy preserves bone tissue in ovariectomized rats.

Sacco SM, Jiang JM, Reza-López S, Ma DW, Thompson LU, Ward WE. Sacco SM, et al. Menopause. 2009 May-Jun;16(3):545-54. doi: 10.1097/gme.0b013e31818fc00a. Menopause. 2009. PMID: 19182694

4

Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.

Hornby SB, Evans GP, Hornby SL, Pataki A, Glatt M, Green JR. Hornby SB, et al. Calcif Tissue Int. 2003 Apr;72(4):519-27. doi: 10.1007/s00223-002-2015-4. Epub 2003 Feb 10. Calcif Tissue Int. 2003. PMID: 12574877

5

Oral bioavailability and bone-sparing effects of estetrol in an osteoporosis model.

Coelingh Bennink HJ, Heegaard AM, Visser M, Holinka CF, Christiansen C. Coelingh Bennink HJ, et al. Climacteric. 2008;11 Suppl 1:2-14. doi: 10.1080/13697130701798692. Climacteric. 2008. PMID: 18464016

6

Dual-energy x-ray absorptiometry of raloxifene effects on the lumbar vertebrae and femora of ovariectomized rats.

Sato M, McClintock C, Kim J, Turner CH, Bryant HU, Magee D, Slemenda CW. Sato M, et al. J Bone Miner Res. 1994 May;9(5):715-24. doi: 10.1002/jbmr.5650090517. J Bone Miner Res. 1994. PMID: 8053401 Free article.

7

Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats.

Iwamoto J, Yeh JK, Schmidt A, Rowley E, Stanfield L, Takeda T, Sato M. Iwamoto J, et al. Calcif Tissue Int. 2005 Aug;77(2):119-26. doi: 10.1007/s00223-004-0277-8. Epub 2005 Jul 28. Calcif Tissue Int. 2005. PMID: 16059775

8

Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis.

Li X, Ominsky MS, Warmington KS, Morony S, Gong J, Cao J, Gao Y, Shalhoub V, Tipton B, Haldankar R, Chen Q, Winters A, Boone T, Geng Z, Niu QT, Ke HZ, Kostenuik PJ, Simonet WS, Lacey DL, Paszty C. Li X, et al. J Bone Miner Res. 2009 Apr;24(4):578-88. doi: 10.1359/jbmr.081206. J Bone Miner Res. 2009. PMID: 19049336 Free article.

9

Sequential effects of chronic human PTH (1-84) treatment of estrogen-deficiency osteopenia in the rat.

Mitlak BH, Burdette-Miller P, Schoenfeld D, Neer RM. Mitlak BH, et al. J Bone Miner Res. 1996 Apr;11(4):430-9. doi: 10.1002/jbmr.5650110403. J Bone Miner Res. 1996. PMID: 8992873 Free article.

10

Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.

Uyar Y, Baytur Y, Inceboz U, Demir BC, Gumuser G, Ozbilgin K. Uyar Y, et al. Maturitas. 2009 Jul 20;63(3):261-7. doi: 10.1016/j.maturitas.2009.03.018. Epub 2009 Apr 21. Maturitas. 2009. PMID: 19386450

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

398 results

Results by year